Company: MVNC
Filing Date: 2025-05-19
Form Type: 10-Q
Source: 0001683168-25-003814
Chunk: 5

Company: Marvion Inc.
Filing Date: 2025-05-19
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
2,761) 
     (511,133)
  
    Net cash used in investing activities 
     (231,570) 
     (511,133)

    Cash flows from financing activities: 

    Advance from a director 
     32,049  
     571,802 
  
    Advance from a shareholder 
     67,099  
     – 
  
    Net cash provided by financing activities 
     99,148  
     571,802 

    Effect of exchange rate on cash and cash equivalents 
     2,458  
     1,522 
  
    Net change in cash and cash equivalents 
     46,365  
     173,287 
  
    Cash and cash equivalents at beginning of the period 
     322,426  
     120,319 
  
    Cash and cash equivalents at end of the period 
    $368,791  
    $293,606 

    Supplemental disclosure of cash flow information: 

    Cash paid for income taxes 
    $–  
    $– 
  
    Cash paid for interest 
    $–  
    $– 
  
    Share issued for settlement of accrued consultancy fees 
    $565,746  
    $– 

See Accompanying Notes to Unaudited Condensed Consolidated
Financial Statements.

 13 

MARVION INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

1.          BASIS
OF PRESENTATION

These accompanying unaudited
condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United
States of America (“US GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and
Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary to make the financial statements not misleading have been included. Operating results for the period ended March 31, 2025 are
not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2025. The information included
in this Quarterly Report on